Detalles de la búsqueda
1.
Prognosis and conditional survival among women with newly diagnosed ovarian cancer.
Gynecol Oncol
; 180: 170-177, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38211405
2.
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 24(4): 392-402, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36878237
3.
Comparison of advanced ovarian cancer patients treated with or without bevacizumab in the US Community Oncology Clinics.
Future Oncol
; 19(16): 1113-1124, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37170823
4.
Efficacy and safety of pemetrexed in elderly cancer patients: results of an integrated analysis.
Crit Rev Oncol Hematol
; 67(1): 64-70, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18358737
5.
Venous and arterial thromboembolism in severe sepsis.
Thromb Haemost
; 99(5): 892-8, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18449418
6.
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
Lung Cancer
; 55(2): 187-94, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17092602
7.
Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial.
Lung Cancer
; 53(1): 77-83, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16730854
8.
Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedules.
Clin Lung Cancer
; 7(3): 202-7, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16354316
9.
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
Clin Lung Cancer
; 7(1): 40-6, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16098243
10.
Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): a combined analysis of three phase 3 trials.
Lung Cancer
; 76(2): 222-7, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22115704
11.
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer.
Crit Rev Oncol Hematol
; 78(2): 162-71, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20413322
12.
Treatment rationale and study design for a randomized trial of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small-cell lung cancer of nonsquamous histology.
Clin Lung Cancer
; 11(5): 352-7, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20837462
13.
A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.
Lung Cancer
; 70(3): 340-6, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20347506
14.
Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.
J Thorac Oncol
; 5(1): 110-6, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20035187
15.
Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer.
J Thorac Oncol
; 5(5): 673-9, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20354453
16.
A Comparison of white and African American outcomes from a three-arm, randomized, phase III multicenter trial of advanced or metastatic non-small cell lung cancer.
J Thorac Oncol
; 5(7): 993-1000, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20593535
17.
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS).
Support Care Cancer
; 17(3): 307-13, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18781341
18.
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer.
J Clin Oncol
; 27(34): 5808-15, 2009 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19884554
19.
Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.
J Thorac Oncol
; 3(4): 394-9, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18379358
20.
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
J Thorac Oncol
; 3(1): 37-45, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18166839